false 0001626878 0001626878 2024-06-20 2024-06-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________________________________

 

FORM 8-K

_____________________________________________

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 20, 2024

_____________________________________________

 

XBIOTECH INC.
(Exact name of Registrant as specified in its charter)

_____________________________________________

 

British Columbia, Canada

(State of Incorporation)

   

001-37347

(Commission File Number)

 

N/A

(I.R.S. Employer Identification No.)

 

5217 Winnebago Ln, Austin, TX 78744
(Address of principal executive offices) (Zip Code)

 

(512) 386-2900

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

The annual meeting of the stockholders of XBiotech Inc. (the “Company”) was held on June 20, 2024. The matters that were voted upon at the meeting, and the number of votes cast for and against, as well as the number of abstentions and broker non-votes as to each such matter, are set forth below. Stockholders voted in accordance with the Board of Directors’ recommendations on each matter and voted to (1) elect five nominees for director; (2) ratify the selection by the Audit Committee of the Board of Directors of Whitley Penn LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.

 

Proposal #1 Election of five members of the Board of Directors

 

  For Abstain Broker Non-Votes
John Simard 9,032,922.58 14,388.00 2,573,795.00
Jan-Paul Waldin 7,407,212.58 1,635,148.00 2,578,745.00
W. Thorpe McKenzie 8,485,018.58 558,511.00 2,577,576.00
Donald MacAdam 8,817,755.58 225,774.00 2,577,576.00
Peter Libby 9,040,330.58 6,980.00 2,573,795.00

 

Proposal #2 Ratification of the selection of Whitley Penn LLP as the Company’s independent registered public accounting firm for the fiscal year ending 2024

 

For Against Abstain Broker Non-Votes
11,411,235.58 146,216.00 63,654.00 0

 

 

 

 

 

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date: June 20, 2024XBIOTECH INC.
    
    
 By: /s/John Simard
   John Simard
   Chief Executive Officer and President

 

 

 

 

 

 

v3.24.1.1.u2
Cover
Jun. 20, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 20, 2024
Entity File Number 001-37347
Entity Registrant Name XBIOTECH INC.
Entity Central Index Key 0001626878
Entity Incorporation, State or Country Code A1
Entity Address, Address Line One 5217 Winnebago Ln
Entity Address, City or Town Austin
Entity Address, State or Province TX
Entity Address, Postal Zip Code 78744
City Area Code (512)
Local Phone Number 386-2900
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
XBiotech (NASDAQ:XBIT)
Historical Stock Chart
Von Nov 2024 bis Dez 2024 Click Here for more XBiotech Charts.
XBiotech (NASDAQ:XBIT)
Historical Stock Chart
Von Dez 2023 bis Dez 2024 Click Here for more XBiotech Charts.